Intercell Completes Equity Private Placement of EUR 15.2 Million at a Price of EUR 2.30 Per New Share

News   May 15, 2012

 
Intercell Completes Equity Private Placement of EUR 15.2 Million at a Price of EUR 2.30 Per New Share
 
 
 

RELATED ARTICLES

Biomedical Catalyst Award Goes To BioMoti, Pharmidex and Queen Mary University of London

News

The grant was awarded under the Biomedical Catalyst funding competition to support preclinical studies of new therapeutic approaches for hard-to-treat tumours including advanced ovarian, triple negative breast and pancreatic cancers.

READ MORE

A New Tactic in the Fight Against Drug-Resistant Infections

News

$1 million research grant could lead to life-saving antibiotics.

READ MORE

New Leprosy Vaccine Launches into Clinical Trials

News

The Infectious Disease Research Institute (IDRI) and American Leprosy Missions announce the start of a Phase 1 clinical trial in humans for a promising leprosy vaccine candidate – the first vaccine developed specifically for leprosy.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE